Hosted on MSN3h
Williams-Sonoma Likely to Issue Cautious 2025 Outlook Amid Softening Demand Trends, Wedbush Says
Williams-Sonoma (WSM) is expected to issue a cautious 2025 outlook when it reports fourth-quarter results next month amid softening demand trends for home furnishings goods, Wedbush Securities said in ...
Wedbush Remains a Buy on C3ai (AI)
In a report released today, Daniel Ives from Wedbush maintained a Buy rating on C3ai (AI – Research Report), with a price target of $45.00. The ...
Legacy Firm Wedbush's First Ever ETF to Focus on AI
Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...
Day One Biopharmaceuticals (NASDAQ:DAWN) Given Outperform Rating at Wedbush
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...
Wedbush Sticks to Its Buy Rating for Pegasystems (PEGA)
Wedbush analyst Daniel Ives maintained a Buy rating on Pegasystems (PEGA – Research Report) today and set a price target of $125.00. The ...
Apple says it will invest $500 billion in U.S. over the next 4 years and hire 20,000 workers
Apple plans to invest $500 billion domestically over the next four years and hire 20,000 additional workers in the U.S., the ...
Why Nvidia (NVDA) Is Advancing Today
Generally, companies are spending 10%-15 of their budgets on AI, and NVDA should benefit from this trend, Wedbush believes.
Can Palantir Become a Trillion-Dollar Stock by 2030?
Recently, Dan Ives of Wedbush Securities suggested that Palantir Technologies ( PLTR -4.63%) could become a trillion-dollar company within the next few years. Should that happen, Palantir would be the ...
Wedbush Reaffirms Their Buy Rating on Spyre Therapeutics (SYRE)
Wedbush analyst David Nierengarten maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) today and set a price target of ...